Abstract
Background
The aim of the present study was to clarify both short-term and long-term results of patients with concomitant hepatocellular carcinoma (HCC) and high-risk oesophagogastric varices (OGV).
Methods
This retrospective study identified 927 cirrhotic patients who underwent curative resection of HCC between 1995 and 2012 in single institution. Patients were separated into 3 groups (A, B, and C) according to general rules for recording endoscopic findings of oesophagogastric varices proposed in Japan in 1991. Groups A, B, and C consisted of patients without OGV (F0), patients with mild to moderate OGV (F1 to F2), and patients with high-risk OGV (F3 and/or red color sign), respectively. All patients in group C underwent prophylactic endoscopic variceal ligation/sclerotherapy. Post-operative complications, mortality, overall survival, and disease-free survival were compared among 3 groups.
Results
No patient had post-operative variceal bleeding. Complication rates of Clavien-Dindo grade II to V in three groups were 13.6, 14.0, and 6.9 %, respectively (P > 0.05). Operative mortality, 5-year overall survival rate, and disease-free survival rate among the 3 groups were not significantly different (P > 0.05).
Conclusions
Prophylactic endoscopic variceal ligation/sclerotherapy effectively prevented from post-operative variceal bleeding in patients with high-risk OGV. Operative mortality, major morbidity, and survival of patients with high-risk OGV were similar to those of patients without OGV or those with mild OGV. Liver resection remains a feasible choice for cirrhotic patients with concomitant HCC and high-risk OGV.
Similar content being viewed by others
References
Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. Lancet 379:1245–1255
Rahbari NN, Mehrabi A, Mollberg NM et al (2011) Hepatocellular carcinoma: current management and perspectives for the future. Ann Surg 253:453–469
Cucchetti A, Ercolani G, Vivarelli M et al (2009) Is portal hypertension a contraindication to hepatic resection? Ann Surg 250:922–928
Santambrogio R, Kluger MD, Costa M et al (2013) Hepatic resection for hepatocellular carcinoma in patients with Child-Pugh’s A cirrhosis: is clinical evidence of portal hypertension a contraindication? HPB (Oxford) 15:78–84
Capussotti L, Ferrero A, Vigano L et al (2006) Portal hypertension: contraindication to liver surgery? World J Surg 30:992–999. doi:10.1007/s00268-005-0524-9
Ishizawa T, Hasegawa K, Aoki T et al (2008) Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology 134:1908–1916
Yao FY, Bass NM, Nikolai B et al (2002) Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl 8:873–883
Llovet JM, Bru C, Bruix J (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19:329–338
Kawano Y, Sasaki A, Kai S et al (2008) Short- and long-term outcomes after hepatic resection for hepatocellular carcinoma with concomitant esophageal varices in patients with cirrhosis. Ann Surg Oncol 15:1670–1676
Idezuki Y (1995) General rules for recording endoscopic findings of esophagogastric varices (1991). Japanese Society for Portal Hypertension. World J Surg 19:420–422 discussion 423
Sobin LH, Gospodarowicz MK, Wittekind C (2009) TNM Classification of Malignant Tumours. Wiley-Blackwell, Oxford, pp 47–48
Malinchoc M, Kamath PS, Gordon FD et al (2000) A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31:864–871
Pugh RN, Murray-Lyon IM, Dawson JL et al (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646–649
Kuo MJ, Yeh HZ, Chen GH et al (2007) Improvement of tissue-adhesive obliteration of bleeding gastric varices using adjuvant hypertonic glucose injection: a prospective randomized trial. Endoscopy 39:487–491
Wu CC, Yeh DC, Lin MC et al (2001) Improving operative safety for cirrhotic liver resection. Br J Surg 88:210–215
Wu CC, Cheng SB, Ho WM et al (2004) Appraisal of concomitant splenectomy in liver resection for hepatocellular carcinoma in cirrhotic patients with hypersplenic thrombocytopenia. Surgery 136:660–668
Jeng KS, Chiang HJ (1989) Delayed formation of gallstone after transcatheter arterial embolization for hepatocellular carcinoma. Is elective cholecystectomy advisable during hepatectomy? Arch Surg 124:1319–1322
Strasberg SM, Belghiti J, Clavien P-A et al (2000) The Brisbane 2000 terminology of liver anatomy and resections. HPB (Oxford) 2:333–339
Belghiti J, Noun R, Malafosse R et al (1999) Continuous versus intermittent portal triad clamping for liver resection: a controlled study. Ann Surg 229:369–375
Wu CC, Yeh DC, Ho WM et al (2002) Occlusion of hepatic blood inflow for complex central liver resections in cirrhotic patients: a randomized comparison of hemihepatic and total hepatic occlusion techniques. Arch Surg 137:1369–1376
Wu CC, Kang SM, Ho WM et al (1998) Prediction and limitation of hepatic tumor resection without blood transfusion in cirrhotic patients. Arch Surg 133:1007–1010
Fan ST, Lo CM, Lai EC et al (1994) Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med 331:1547–1552
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213
Ishizawa T, Hasegawa K, Kokudo N et al (2009) Risk factors and management of ascites after liver resection to treat hepatocellular carcinoma. Arch Surg 144:46–51
Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421–430
Bruix J, Castells A, Bosch J et al (1996) Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 111:1018–1022
Nanashima A, Sumida Y, Abo T et al (2009) Treatment of concomitant gastric varices in patients with hepatocellular carcinoma at a single Japanese institute. Hepatogastroenterology 56:857–860
Sugo H, Fujiwara N, Yoshimoto J et al (2008) Additional Hassab’s operation for esophagogastric varices in cirrhotic patients with resectable hepatocellular carcinoma. Hepatogastroenterology 55:1686–1690
Miyazaki M, Kimura F, Shimizu H et al (2007) Surgical treatment for liver cancer. Current issues. Dig Surg 24:120–125
Beppu K, Inokuchi K, Koyanagi N et al (1981) Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc 27:213–218
Stremitzer S, Tamandl D, Kaczirek K et al (2011) Value of hepatic venous pressure gradient measurement before liver resection for hepatocellular carcinoma. Br J Surg 98:1752–1758
Zaman A, Becker T, Lapidus J et al (2001) Risk factors for the presence of varices in cirrhotic patients without a history of variceal hemorrhage. Arch Intern Med 161:2564–2570
Tapper EB, Robson SC, Malik R (2013) Coagulopathy in cirrhosis: the role of the platelet in hemostasis. J Hepatol 59:889–890
Makuuchi M, Imamura H, Sugawara Y et al (2002) Progress in surgical treatment of hepatocellular carcinoma. Oncology 62(Suppl 1):74–81
Torzilli G, Belghiti J, Kokudo N et al (2013) A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?: an observational study of the HCC East-West study group. Ann Surg 257:929–937
Fan ST, Mau Lo C, Poon RT et al (2011) Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experience. Ann Surg 253:745–758
Minagawa M, Ikai I, Matsuyama Y et al (2007) Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg 245:909–922
Poon RT, Fan ST, Lo CM et al (2002) Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 235:373–382
Chok KS, Ng KK, Poon RT et al (2009) Impact of postoperative complications on long-term outcome of curative resection for hepatocellular carcinoma. Br J Surg 96:81–87
Fujiki M, Aucejo F, Kim R (2011) General overview of neo-adjuvant therapy for hepatocellular carcinoma before liver transplantation: necessity or option? Liver Int 31:1081–1089
Mazzaferro V, Battiston C, Perrone S et al (2004) Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg 240:900–909
Graziadei IW, Sandmueller H, Waldenberger P et al (2003) Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl 9:557–563
Acknowledgments
The authors thank the Department of Medical Research of Taichung Veterans General Hospital for statistical assistance.
Conflict of interest
Potential and real conflicts of interest: none declared.
Author information
Authors and Affiliations
Corresponding author
Additional information
Hsiao-Tien Liu and Shao-Bin Cheng equally contributed to this article.
Rights and permissions
About this article
Cite this article
Liu, HT., Cheng, SB., Wu, CC. et al. Impact of Severe Oesophagogastric Varices on Liver Resection for Hepatocellular Carcinoma in Cirrhotic Patients. World J Surg 39, 461–468 (2015). https://doi.org/10.1007/s00268-014-2811-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-014-2811-9